|
- Rizmoic - European Medicines Agency (EMA)
Rizmoic is a medicine for treating constipation caused by opioid pain relief medicines in patients who have previously been treated with a laxative (a medicine that triggers bowel movements) It contains the active substance naldemedine
- Naldemedine - Wikipedia
Naldemedine, sold under the brand name Symproic in the US and Rizmoic in the European Union, is a medication that is used for the treatment of opioid-induced constipation in adults
- Rizmoic 200 micrograms film-coated tablets - medicines
Rizmoic is indicated for the treatment of opioid-induced constipation (OIC) in adult patients who have previously been treated with a laxative
- Rizmoic: Uses, Dosage, Side Effects, Food Interaction FAQ
Rizmoic is an opioid receptor antagonist with restricted movement across the blood brain barrier [FDA Label] This allows it to antagonize the periperal effects of opioid drugs such as constipation without interfering with the effects on the central nervous system
- Naldemedine | Drugs | BNF | NICE
Naldemedine (Rizmoic®) for the treatment of opioid-induced constipation (OIC) in adult patients who have previously been treated with a laxative (April 2020)
- Rizmoic - patient leaflet, side effects, dosage
Rizmoic contains the active substance naldemedine It is a medicine used in adults to treat constipation caused by pain medicines, called opioids (e g morphine, oxycodone, fentanyl, tramadol, codeine, hydromorphone, methadone) Your opioid pain medicine may cause the following symptoms:
- Rizmoic 200 mcg: Scheda Tecnica e Prescrivibilità
Rizmoic 200 mcg - Naldemedina - Rizmoic è indicato per il trattamento della stipsi indotta da oppioidi (Opioid-Induced Constipation, OIC) nei pazienti adulti che sono stati trattati in precedenza con un lassativo
- RIZMOIC 200 µg cp pellic - VIDAL
Rizmoic est indiqué dans le traitement de la constipation induite par les opioïdes (CIO) chez les patients adultes ayant été traités préalablement par un laxatif
|
|
|